The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
about
Bisphosphonates for advanced prostate cancerOsteochemonecrosis: an overviewA novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosisBone health and prostate cancer.Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma.Bisphosphonates' antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay.Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jawEvolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric studyEstablishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.Adjuvant pamidronate therapy prevents the development of bone metastases in breast cancer patients with four or more positive nodes.Bisphosphonate-Induced Osteonecrosis of the Maxilla Resembling a Persistent Endodontic Lesion.Zoledronic acid in the management of metastatic bone disease.Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevanceUpdates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis.Treatment options for breast cancer and bone metastases.Radiography finding in the jaws in children taking bisphosphonate.Bisphosphonates as adjuvant therapy for breast cancer.Bisphosphonate-related osteonecrosis of the jaws and its relevance to children--a review.Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.Contemporary pharmacotherapy for the prevention of skeletal complications in patients with prostate cancer.Zoledronic acid is effective against experimental malignant pleural effusion.Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesions.Bisphosphonates and osteonecrosis of the jaw: a case report.Zoledronate-induced remission of acute panmyelosis with myelofibrosis.Exposure to bisphosphonates and risk of colorectal cancer: a population-based nested case-control study.Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.Bisphosphonate-induced osteonecrosis of the maxilla presenting as a cicatricial ectropion.153Sm: its use in multiple myeloma and report of a clinical experience
P2860
Q24244161-78B5B999-5245-41DB-B3E6-619F322EE4C0Q26827072-8613DC66-956B-4963-B4C3-6E99F1D37157Q33810748-39E89241-1C4F-4C79-97D2-BA951A8A3A9FQ33977536-9FD9D638-DA2D-4E7C-B7C5-DE456B0D6700Q34122791-F94C6770-5EB0-4A56-96C3-F8AEEC67F93EQ34870857-AE2E8A74-369A-4DCA-9752-41195C3553BEQ35219480-5A926F91-7B53-4448-87A4-54CD078C13D3Q35865686-1CC12BC1-4AA7-4B34-94F0-285621F5B6C8Q35867167-03F7D783-8D78-460D-92A0-ACDDE620F99DQ35920063-0F7585F2-BF56-4444-B590-F9A8F1F93339Q36216730-C1C7CC21-8534-4EB0-94F5-40E45BC4E049Q36516261-9372278A-3788-4AE9-BF7B-F82F105C60B1Q36708315-AEB2029E-E811-4F72-A8CA-04818D63B314Q37019257-28CE6418-707E-4980-AD15-FF7B34ECF904Q37108645-72759EC3-5F24-496D-A6B8-8BB34B3B1C15Q37401841-B86D80D9-4C8A-4D5E-B4F1-1EF64221438EQ37579282-310B0386-857D-4380-BCAC-E23B002A3E1BQ37608380-A27FC296-372C-412D-BFAF-BB9FF5929420Q38122724-B7DA0FC2-0FE5-4598-B63F-57624BA9ADE6Q38130312-CFBD96FF-3B3A-4B7C-A1A1-AFED5F5735CFQ38252425-86267CA7-FAC2-44EE-9156-E0B8EF147F46Q39995123-71AA09E0-EDA5-4771-850D-3A5C784A3F28Q40181960-2A850DC2-B3EB-4605-9920-013FDC91F29EQ40252845-C4512E9C-1B1E-4146-A61F-E881B1E43858Q42132237-A7E3EAC5-8493-4100-A7A4-103DD45CD770Q43034724-8624A837-7674-4C05-B478-53BA37099F28Q43151851-0BD37CCA-12DF-492E-A68B-0E6050DC7526Q45002808-3786A2E1-8DBA-4576-B330-46711C7A754BQ45075711-F8B81F19-5FE1-4684-BE33-679B27591029Q51514887-260581CD-5818-4C72-99ED-5EB5A848A655Q53063200-2B753F2C-EAA0-47BF-A575-3EDED298A77CQ58449064-AFF411C0-7250-4732-93BE-E1CDC1805E8B
P2860
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
@ast
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
@en
type
label
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
@ast
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
@en
prefLabel
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
@ast
The antineoplastic role of bisphosphonates: from basic research to clinical evidence.
@en
P2093
P50
P356
P1433
P1476
The antineoplastic role of bisphosphonates: from basic research to clinical evidence
@en
P2093
P304
P356
10.1093/ANNONC/MDG401
P577
2003-10-01T00:00:00Z